The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry

Therapeutic Drug Monitoring
Wei HuangElinore F McCance-Katz

Abstract

The opioid partial agonist medication, buprenorphine (BUP), and its primary metabolite, norbuprenorphine (NBUP), are extensively glucuronidated. Sensitive analytical methods that include determination of buprenorphine-3-glucuronide (BUPG) and norbuprenorphine-3-glucuronide (NBUPG) are needed to more fully understand the metabolism and pharmacokinetics of buprenorphine. A method has now been developed that uses solid-phase extraction followed by liquid chromatography-electrospray ionization-tandem mass spectrometry. BUP-d4, NBUP-d3, and morphine-3-glucuronide-d3 were used as internal standards. The lower limit of quantitation was 0.1 and 0.5 ng/mL for each of the analytes in 1-mL of human plasma and urine, respectively, except for NBUP in urine in which it was 2.5 ng/mL. The analytes were stable under the following conditions: plasma and urine at room temperature, up to 20 hours; plasma and urine at -20 degrees C for 119 and 85 days, respectively; plasma freeze-thaw, up to 3 cycles; processed sample, up to 96 hours at -20 degrees C and up to 48 hours on the autosampler; stock solutions at room temperature and at -20 degrees C, up to 6 hours and 128 days, respectively. In plasma collected from 5 subjects on maintenance daily subl...Continue Reading

References

Aug 1, 1977·British Journal of Pharmacology·A CowanI R Macfarlane
Jan 1, 1991·Pharmacology & Therapeutics·J O Miners, P I Mackenzie
Feb 1, 1995·Molecular Biology of the Cell·J M Lewis, M A Schwartz
Jul 1, 1994·The American Journal of Psychiatry·E C StrainG E Bigelow
May 1, 1994·Clinical Pharmacology and Therapeutics·S L WalshG E Bigelow
May 1, 1996·Archives of General Psychiatry·W LingC J Klett
Oct 1, 1996·Journal of Analytical Toxicology·J J KuhlmanW D Darwin
Oct 20, 1998·Journal of Pharmaceutical and Biomedical Analysis·F LagrangeB Begaud
Oct 12, 1999·Journal of Analytical Toxicology·D E MoodyA C Spanbauer
Nov 4, 2000·The New England Journal of Medicine·R E JohnsonG E Bigelow
May 8, 2001·Journal of Chromatography. B, Biomedical Sciences and Applications·A Polettini, M A Huestis
Aug 7, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mark K GreenwaldJon-Kar Zubieta
Nov 11, 2003·Journal of Analytical Toxicology·Robert KronstrandMartin Josefsson
Apr 10, 2004·Drug and Alcohol Dependence·Eric C StrainGeorge E Bigelow

❮ Previous
Next ❯

Citations

Apr 13, 2007·Analytical and Bioanalytical Chemistry·Frank T Peters
Sep 18, 2007·European Journal of Clinical Pharmacology·Mette L JensenLona Christrup
Jan 30, 2010·International Journal of Legal Medicine·Stephanie Oechsler, Gisela Skopp
Mar 26, 2011·Bioconjugate Chemistry·Jinda FanEvan D Kharasch
Nov 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Elinore F McCance-KatzPetrie M Rainey
Nov 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Elinore F McCance-KatzPetrie M Rainey
Mar 16, 2012·Journal of Analytical Toxicology·Stacy E F MelansonJames G Flood
Sep 24, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·David E MoodyCurtis J Omiecinski
Nov 22, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Valerie A GruberElinore F McCance-Katz
Dec 17, 2009·Forensic Science International : Synergy·Stephanie Oechsler, Gisela Skopp
Oct 24, 2007·Peptides·Richard J Bodnar
Jun 9, 2009·Basic & Clinical Pharmacology & Toxicology·David E MoodyElinore F McCance-Katz
Feb 6, 2010·The American Journal on Addictions·Elinore F McCance-KatzDavid E Moody
Feb 6, 2010·The American Journal on Addictions·Elinore F McCance-KatzPetrie M Rainey
May 21, 2011·Drug and Alcohol Dependence·Elinore F McCance-KatzPetrie M Rainey
Apr 26, 2011·Drug and Alcohol Dependence·David E MoodyElinore McCance-Katz
Dec 7, 2014·Journal of Substance Abuse Treatment·Jeanette M TetraultLynn E Fiellin
Jul 24, 2007·Drug and Alcohol Dependence·Elinore F McCance-KatzPetrie M Rainey
Mar 6, 2018·Basic & Clinical Pharmacology & Toxicology·David E MoodyWenfang B Fang
Aug 29, 2014·The American Journal of Hospice & Palliative Care·Eric Prommer
Mar 9, 2018·Clinical Pharmacology and Therapeutics·Jason N MooreWalter K Kraft
Jan 3, 2007·Journal of Mass Spectrometry : JMS
Mar 29, 2011·The American Journal of Drug and Alcohol Abuse·R Douglas BruceGerald H Friedland
Dec 20, 2014·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Dayong LeeBruce A Goldberger
Dec 10, 2013·The American Journal on Addictions·Carmen L MassonElinore F McCance-Katz
Dec 31, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yan ChangElinore F McCance-Katz
Feb 13, 2019·Journal of Analytical Toxicology·Birthe SchubertMarion Pavlic
Jul 21, 2021·Journal of the American Association for Laboratory Animal Science : JAALAS·Niora J FabianJennifer L Haupt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.